Immuron Limited ADRIMC
Price$1.13

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.4M0.0% YoYTTM through 30 Jun 2025
Net Income -$3.4MTTM through 30 Jun 2025
Free Cash Flow -$6.1MTTM through 30 Jun 2025

Margins

Current
Gross Margin65.4%
Operating Margin-85.8%
Net Margin-145.6%

Returns

-65.1%ROE
-50.3%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio5.10x
Net Debt-$5.9Mnet cash position
Cash & Equivalents$2.7M

Quality Metrics

FCF Margin-260.9%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $7.3M
Diluted EPS
'22'23'24'25
FY2025: $-0.02

Dividend

No dividend
Financials converted at 1.5202 from AUD.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.